NCI Community Oncology Research Program - Kansas City (NCORP-KC)
NCI Community Oncology Research Program - Kansas City (NCORP-KC)




Leukemia Clinical Trials

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

 

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.



Acute

ECOG-ACRIN E1910 - "A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults"

CANCER TYPE: Acute
RESEARCH BASE: CTSU E1910
NCT NUMBER: 02003222
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
BRIEF DESCRIPTION

ALL, new dx, B-lineage BCR/ABL negative, age >=30 & <=70, BM & perip blood must be submitted pre-regist; Eval of Blinatumomab.  DCP-001 Eligible






SWOG S1612 - "A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older"

CANCER TYPE: Acute
RESEARCH BASE: SWOG
NCT NUMBER: NCT03092674
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
Additional Consent Form: VIEW CONSENT FORM 2
BRIEF DESCRIPTION

Untreated AML or MDS with excess blasts,  ≥ 60 years of age, FLT3 testing, Azacitidine vs. Azacitidine + Nivolumab vs. Azacitidine + Midostaurin vs. Decitabine + Cytarabine









  © 2013-2018 All Rights Reserved. Privacy Policy | Terms & Conditions
NCI Community Oncology Research Program - Kansas City (NCORP-KC)
Questions? Call: +1-913-948-5588 | Contact Us
4121 W. 83rd St., Suite 259 Prairie Village, KS 66208 USA